Spirocyclic quinazoline derivatives as PDE7 inhibitors

Details for Australian Patent Application No. 2006321349 (hide)

Owner Pfizer Limited

Inventors Rawson, David James; Swain, Nigel Alan

Agent Shelston IP

Pub. Number AU-A-2006321349

PCT Pub. Number WO2007/063391

Priority 60/741,854 02.12.05 US; 60/791,186 10.04.06 US

Filing date 23 November 2006

Wipo publication date 7 June 2007

International Classifications

C07D 239/80 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/522 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/063391 Priority application(s): WO2007/063391

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006321352-Circuit breaker including open neutral interlock

2006321346-Coal upgrading process utilizing nitrogen and/or carbon dioxide